Management of Cutaneous Immune-Related Adverse Events in Patients With Cancer Treated With Immune Checkpoint Inhibitors
Author:
Affiliation:
1. Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston
Publisher
American Medical Association (AMA)
Subject
Oncology,Cancer Research
Link
https://jamanetwork.com/journals/jamaoncology/articlepdf/2785675/jamaoncology_nadelmann_2021_rv_210009_1642642433.33344.pdf
Reference75 articles.
1. Estimation of the percentage of US patients with cancer who are eligible for immune checkpoint inhibitor drugs.;Haslam;JAMA Netw Open,2020
2. Inflammatory eruptions associated with immune checkpoint inhibitor therapy: a single-institution retrospective analysis with stratification of reactions by toxicity and implications for management.;Coleman;J Am Acad Dermatol,2019
3. Survivorship in immune therapy: assessing chronic immune toxicities, health outcomes, and functional status among long-term ipilimumab survivors at a single referral center.;Johnson;Cancer Immunol Res,2015
4. Ipilimumab may increase the severity of cutaneous toxicity related to radiotherapy.;Eryilmaz;J Oncol Pharm Pract,2016
5. Treatment of skin reaction induced by nivolumab combined with radiotherapy in non–small cell lung cancer: a case report.;Zhao;Chin Med Sci J,2018
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cutaneous side effects of treatment with immune checkpoint inhibitors;Ugeskrift for Læger;2024-07-15
2. Nivolumab‐induced lichenoid penile ulceration and re‐emergent mucocutaneous eruption treated with hydroxychloroquine;Australasian Journal of Dermatology;2024-02-09
3. Experiences of immune-related skin toxicity: a qualitative study among patients with cancer;2024-02-01
4. Roles of tissue-resident immune cells in immunotherapy of non-small cell lung cancer;Frontiers in Immunology;2023-12-07
5. How to recognize and manage skin toxicities associated with immune checkpoint inhibitors: a practical approach;British Journal of Dermatology;2023-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3